文献速递主动脉疾病外周动脉疾病

Gore Excluder 髂支内假体治疗日本主髂动脉瘤患者的结局:基于 J-Preserve 登记的研究

Outcomes of the Gore Excluder Iliac Branch Endoprosthesis for Japanese Patients With Aortoiliac Aneurysms: A Study Based on J-Preserve Registry.
PubMed 文献 · J Endovasc Ther · 2022-07-11

本研究为多中心回顾性队列研究(J-Preserve 登记),纳入 2017 年 8 月至 2020 年 6 月期间接受 Gore Excluder 髂支内假体(IBE)腔内修复主髂动脉瘤的日本患者 141 例、IBE 植入 151 例次。总体技术成功率 96.7%,髂内动脉主干与分支着陆组间 IBE 相关并发症及再干预无显著差异,随访期间无动脉瘤相关死亡或破裂,结论认为该装置在中期的安全有效,将髂内动脉装置延伸至远端分支可接受。

要点

  • 141 例患者共 151 例次 IBE 植入,总体技术成功率 96.7%。
  • 43.0% 的 IBE 植入存在至少一项使用说明违规。
  • 髂内动脉主干与分支着陆组的 IBE 相关并发症及再干预无显著差异。

核心结论

  • Gore Excluder IBE 对日本患者中期安全有效。
  • 将髂内动脉装置延伸至髂内动脉远端分支是可接受的,可能使主髂动脉瘤腔内修复的适应证扩展至更复杂病变。

研究设计与样本

  • 多中心回顾性队列研究(J-Preserve 登记)。
  • 纳入 2017 年 8 月至 2020 年 6 月期间因主髂动脉瘤接受 Gore Excluder IBE 腔内主动脉修复的患者。
  • 共纳入 141 例患者、151 例次 IBE 植入。
  • 主要终点为技术成功、IBE 相关并发症和再干预;次要终点为死亡率、动脉瘤大小变化和随访期间再干预。
  • 技术成功定义为 IBE 准确释放且完成造影时 IBE 侧无 Ib、Ic 或 III 型内漏;动脉瘤大小变化≥5 mm 视为显著变化。

主要发现

  • 65 例次 IBE 植入(43.0%)存在至少一项使用说明违规。
  • 22 例患者(15.6%)因对侧髂外动脉延伸需要行髂内动脉栓塞。
  • 151 例次 IBE 植入中,19 例次因髂内动脉瘤而存在髂内动脉分支着陆区。
  • 平均最大髂总动脉直径 32.9±9.9 mm,近端髂总动脉直径 20.5±6.9 mm,髂总动脉长度 59.1±17.1 mm;髂内动脉着陆直径 9.0±2.3 mm、长度 33.8±14.6 mm。
  • 总体技术成功率 96.7%;髂内动脉主干着陆组与分支着陆组的 IBE 相关并发症(2.3% vs 5.3%,p=0.86)及 IBE 相关再干预(1.5% vs 5.3%,p=0.33)无显著差异。

临床怎么用

  • 作者认为 Gore Excluder IBE 对日本患者中期安全有效。
  • 作者认为将髂内动脉装置延伸至髂内动脉远端分支是可接受的,可能使主髂动脉瘤腔内修复的适应证扩展至更复杂病变。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: To evaluate the clinical utility of the Gore Excluder iliac branch endoprosthesis (IBE) for Japanese patients with aortoiliac aneurysms. MATERIALS AND METHODS: This was a multicenter retrospective cohort study (J-Preserve Registry). Patients undergoing endovascular aortic repair using the Gore Excluder IBE for aortoiliac aneurysms between August 2017 and June 2020 were enrolled. Data pertaining to the baseline and anatomical characteristics, technical details, and clinical outcomes were collected from each institution. The primary endpoints were technical success, IBE-related complications, and reinterventions. Secondary endpoints were mortality, aneurysm size change, and reintervention during follow-up. Technical success was defined as accurate deployment of the IBE without type Ib, Ic, or III endoleaks on the IBE sides on completion angiography. A change in aneurysm size of 5 mm or more was taken to be a significant change. RESULTS: We included 141 patients with 151 IBE implantations. Sixty-five IBE implantations (43.0%) had at least one instruction for use violation. Twenty-two patients (15.6%) required internal iliac artery (IIA) embolization for external iliac artery extension on the contralateral side. Of 151 IBE implantations, 19 exhibited IIA branch landing zones due to IIA aneurysms. Mean maximum and proximal common iliac artery (CIA) diameters were 32.9±9.9 mm and 20.5±6.9 mm, respectively. The mean CIA length was 59.1±17.1 mm. The IIA landing diameter and length were 9.0±2.3 mm and 33.8±14.6 mm. The overall technical success rate was 96.7%. There were no significant differences in IBE-related complications (2.3% vs 5.3%, p=0.86) or IBE-related reinterventions (1.5% vs 5.3%, p=0.33) between the IIA trunk and IIA branch landing groups. The mean follow-up period was 635±341 days. The all-cause mortality rate was 5.0%. There were no aneurysm-related deaths or ruptures during the follow-up. Most patients (95.7%) had sac stability or shrinkage. CONCLUSION: The Gore Excluder IBE was safe and effective for Japanese patients in the midterm. Extending the IIA device into the distal branches of the IIA was acceptable, which may permit extending indications for endovascular aortic aneurysm repair of aortoiliac aneurysms to more complex lesions. CLINICAL IMPACT: This study suggests clinical benefits of the Gore Excluder IBE for Japanese patients, despite 43% of the IBE implantations having at least one IFU violation.

来源:J Endovasc Ther,查看原文。版权归原作者所有。

引用

  1. Ogawa Y, Fujimura N, Yamaguchi M, et al. Outcomes of the Gore Excluder Iliac Branch Endoprosthesis for Japanese Patients With Aortoiliac Aneurysms: A Study Based on J-Preserve Registry. J Endovasc Ther. 2022. PMID: 35815459. doi:10.1177/15266028221109477

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。